<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02086435</url>
  </required_header>
  <id_info>
    <org_study_id>SafeMorcellation</org_study_id>
    <nct_id>NCT02086435</nct_id>
  </id_info>
  <brief_title>Intracorporeal Versus Extracorporeal Morcellation: Clinical Efficacy and Safety Outcomes</brief_title>
  <acronym>IEME</acronym>
  <official_title>A Randomized Controlled Trial on Intracorporeal Versus Extracorporeal Morcellation With Endobag Extraction in Patients Undergoing Laparoscopic Myomectomy: Clinical Efficacy and Safety Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Magna Graecia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Magna Graecia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study protocol will be to compare the technique of intracorporeal
      morcellation using reusable electronic device (standard technique) with a technique of
      removal &quot;protected&quot; by endobag and extracorporeal myoma morcellation with cold scissors and
      scalpel blade or with power morcellator used inside the bag itself.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operative time</measure>
    <time_frame>The day of surgery</time_frame>
    <description>calculated from the time, after secured hemostasis of the uterine breach, in which the myoma is clamped and subjected to intracorporeal or added in endobag for extracorporeal morcellation to the moment when the 'last fragment of myoma will be considered removed from the surgical field</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total operative time</measure>
    <time_frame>The day of surgery</time_frame>
    <description>from skin incision to skin closure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Handling of morcellation</measure>
    <time_frame>The day of surgery</time_frame>
    <description>expressed on the VAS scale where 1 means very bad handling and 10 excellent handling</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>2 hours after the end of surgery</time_frame>
    <description>Blood loss will be calculated by the difference of Hb level 2 hours after surgery and the morning of the surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital stay</measure>
    <time_frame>The day of patient discharge, average 4 day after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>The day of patient discharge, average 4 day after surgery</time_frame>
    <description>measured on the VAS scale where 1 stands for a little pain and 10 for intense pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of complications</measure>
    <time_frame>The day of patient discharge, average 4 day after surgery</time_frame>
    <description>need of transfusion or laparotomic conversion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">93</enrollment>
  <condition>Uterine Myoma</condition>
  <arm_group>
    <arm_group_label>Extracorporeal morcellation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extracorporeal morcellation in which patients are treated with &quot;protected&quot; removal by endobag and extracorporeal myoma morcellation with cold scissors and scalpel blade or with power morcellator used inside the bag itself</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intracorporeal morcellation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intracorporeal morcellation patients treated with standard intracorporeal morcellation, using reusable electronic device</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Extracorporeal morcellation</intervention_name>
    <description>patients treated with &quot;protected&quot; removal by endobag and extracorporeal myoma morcellation with cold scissors and scalpel blade or with power morcellator used inside the bag itself</description>
    <arm_group_label>Extracorporeal morcellation</arm_group_label>
    <other_name>protected morcellation</other_name>
    <other_name>morcellation in endobag</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intracorporeal morcellation</intervention_name>
    <description>patients treated with standard intracorporeal morcellation, using reusable electronic device</description>
    <arm_group_label>Intracorporeal morcellation</arm_group_label>
    <other_name>Power morcellation</other_name>
    <other_name>Standard intracorporeal morcellation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing laparoscopy for uterine myomas with international guidelines
             surgical indications

          -  Presence of at least one uterine myoma larger than 4 cm

          -  Aged between 18 and 40 years

        Exclusion Criteria:

          -  Presence of uterine neoformations suspicious for malignancy

          -  Medical major disorders associated

          -  Acute or chronic psychiatric disorders

          -  Ascertained Premenstrual syndrome

          -  Use of drugs that can affect cognitive ability or state of consciousness and alertness
             during the last six months prior to enrollment

          -  Presence of calcified fibroids ultrasound examination

          -  Presence of adnexal lesions

          -  Detection of a pattern of endometrial hyperplasia with atypia determined in the course
             endometrial biopsy performed for abnormal uterine bleeding

          -  Abnormal PAP test

          -  Positive Pregnancy Test

          -  Previous use of laparoscopic surgery increased
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fulvio Zullo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Magna Graecia University of Catanzaro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chair of Obstetrics and Gynecology - University division - UMG</name>
      <address>
        <city>Catanzaro</city>
        <state>CZ</state>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2014</study_first_submitted>
  <study_first_submitted_qc>March 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2014</study_first_posted>
  <last_update_submitted>April 19, 2015</last_update_submitted>
  <last_update_submitted_qc>April 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Magna Graecia</investigator_affiliation>
    <investigator_full_name>Fulvio Zullo</investigator_full_name>
    <investigator_title>Full Professor Obstetric Gynecology</investigator_title>
  </responsible_party>
  <keyword>Myomectomy</keyword>
  <keyword>Laparoscopic myomectomy</keyword>
  <keyword>Morcellation</keyword>
  <keyword>Risk of dissemination</keyword>
  <keyword>Uterine Sarcoma</keyword>
  <keyword>Parasitic myoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

